Correlation Between Novartis and TC BioPharm
Can any of the company-specific risk be diversified away by investing in both Novartis and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and TC BioPharm Holdings, you can compare the effects of market volatilities on Novartis and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and TC BioPharm.
Diversification Opportunities for Novartis and TC BioPharm
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Novartis and TCBP is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Novartis i.e., Novartis and TC BioPharm go up and down completely randomly.
Pair Corralation between Novartis and TC BioPharm
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.17 times more return on investment than TC BioPharm. However, Novartis AG ADR is 6.01 times less risky than TC BioPharm. It trades about 0.29 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.12 per unit of risk. If you would invest 9,714 in Novartis AG ADR on November 3, 2024 and sell it today you would earn a total of 758.00 from holding Novartis AG ADR or generate 7.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novartis AG ADR vs. TC BioPharm Holdings
Performance |
| Timeline |
| Novartis AG ADR |
| TC BioPharm Holdings |
Novartis and TC BioPharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and TC BioPharm
The main advantage of trading using opposite Novartis and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
| TC BioPharm vs. ZyVersa Therapeutics | TC BioPharm vs. Palisade Bio | TC BioPharm vs. Unicycive Therapeutics | TC BioPharm vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |